Browsing: Stock

US stock futures traded mixed on Thursday after President Trump vowed to squeeze Iran economically and the US Treasury’s surprise move to intervene in the bond market caused Treasury yields to retreat and cryptocurrencies to surge

Cracks are starting to show in the US economy, but one top investment chief is saying to stick with the cyclical trade

We’ve been stuck in this either/or market for what seems like an eternity. Perhaps it’s time that everything moves together

Nova Scotia Premier Tim Houston says Prime Minister Mark Carney has asked provinces to restock American alcohol on their shelves as Canada finalizes a trade deal with the U.S

Major market indexes have been soaring lately, with the S&P 500 (SNPINDEX: ^GSPC), Nasdaq Composite (NASDAQINDEX: ^IXIC), and Dow Jones Industrial Average (DJINDICES: ^DJI) up by 6%, 9%, and 4%, respectively, since late July alone

Shares of fabless chip and software maker Broadcom (NASDAQ:AVGO) fell 3.9% in the afternoon session after its competitor Marvell Technology landed a deal to develop custom artificial intelligence (AI) chips for Google. 

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, developed with Merck, met key goals in a late-stage trial. 

Moderna (NASDAQ:MRNA), an mRNA medicine and preventive vaccines provider, closed at $174.38, up 176.97%. Shares surged after Moderna and Merckreported positive Phase 3 melanoma data. Investors are watching for FDA plans and further developments for the treatment. Trading volume reached 185.1M shares, coming in about 1,819% above its three-month average of 9.6M shares. Moderna IPO’d…

Moderna (MRNA) stock exploded over 100% in Wednesday pre-market trading, hitting $122.51 after the company and Merck (MRK) reported the first positive Phase 3 result for a personalized mRNA cancer vaccine

Marvell Technology Inc. stocks have been trading up by 8.33 percent amid upbeat AI chip demand and revenue growth expectations